Genasys Inc. Reports Fiscal First Quarter 2023 Financial Results
Genasys Inc. (NASDAQ: GNSS) reported strong fiscal Q1 results with record SaaS bookings of $6.1 million, driven by contracts from Aramco and several California counties. Q1 revenue reached $10.5 million, down 2% year-over-year, with a 64% increase in software revenue but a 5% drop in hardware revenue. Gross profit margin declined to 43.3% due to higher costs. The net loss widened to $3.5 million, or ($0.10) per share. International bookings accounted for 50% of total, with notable growth in the APAC region. Genasys reaffirmed its outlook for continued revenue growth in fiscal 2023, fueled by increasing international sales and ongoing software investments.
- Record SaaS bookings of $6.1 million, the largest in company history.
- Software revenue increased by 64%, showcasing strong demand.
- International bookings accounted for 50% of total, with APAC revenue doubling year-over-year.
- Revenue declined by 2% year-over-year to $10.5 million.
- Gross profit margin decreased to 43.3% from 48.2% due to rising component costs.
- Net loss increased to $3.5 million, compared to $1.3 million in the previous year.
Strong Fiscal Q1 SaaS Bookings Position Company for Significant SaaS Revenue Growth
SAN DIEGO, Feb. 09, 2023 (GLOBE NEWSWIRE) -- Genasys Inc. (NASDAQ: GNSS), the global leader in critical communications systems and solutions that help keep people safe, today announced financial results for the Company’s fiscal first quarter ended December 31, 2022.
Richard S. Danforth, Chief Executive Officer of Genasys, Inc., commented, "We are off to a strong start in fiscal year 2023 with our largest SaaS bookings quarter to date. Our software business continues to gain momentum, as evidenced by the
"Our International results were also robust in the quarter, as our strategy to regionalize business development by establishing sales offices, in APAC, Europe, and the Middle East has proven successful," continued Mr. Danforth. "During the fiscal first quarter,
Mr. Danforth added, "In what is typically our slowest quarter, fiscal first quarter revenue was
Mr. Danforth continued, "In order to achieve our growth objectives, we are committed to continuing our SaaS business investment. Our SaaS systems suite is evolving to meet the complex needs of jurisdictions and enterprises as they strive to keep their people safe. This includes the integration of GEM, Zonehaven, and IMNS into a seamless protective communications platform. The new platform empowers Genasys to address a much larger scope of multi-hazard enterprise and public safety crises, including hurricanes, storm surges, tsunamis, avalanches, flooding, debris flows, wildfires, chemical plumes, active shooter incidents, and other natural and man-made disasters."
Business Outlook
Mr. Danforth concluded, "We are reiterating our fiscal 2023 outlook for continued revenue growth with stronger international sales, continuing LRAD deliveries to the U.S. military, increasing software services sales, and significant SaaS revenue growth."
Fiscal First Quarter 2023 Financial Summary
Fiscal first quarter revenue was
Gross profit margin was
Operating expenses were
Net loss in the quarter was
Adjusted EBITDA was (
Cash, cash equivalents and marketable securities totaled
We include in this press release Non-GAAP operational metrics of adjusted EBITDA, backlog and bookings, which we believe provide helpful information to investors with respect to evaluating the Company’s performance. Adjusted EBITDA represents our net income before other income, net, income tax expense (benefit), depreciation and amortization expense and stock-based compensation. We do not consider these items to be indicative of our core operating performance. The items that are non-cash include depreciation and amortization expense and stock-based compensation. Adjusted EBITDA is a measure used by management to understand and evaluate our core operating performance and trends and to generate future operating plans, make strategic decisions regarding allocation of capital and invest in initiatives that are focused on cultivating new markets for our solutions. In particular, the exclusion of certain expenses in calculating adjusted EBITDA facilitates comparisons of our operating performance on a period-to-period basis. We consider bookings as leading indicators of future revenues and use these metrics to support production planning. Bookings is an internal, operational metric that measures the total dollar value of customer purchase orders executed in a period, regardless of the timing of the related revenue recognition. Backlog is a measure of purchase orders received that are planned to ship within the next 12 months.
Webcast and Conference Call Details
Management will host a conference call to discuss the financial results for the first quarter of fiscal year 2023 this afternoon at 4:30 p.m. Eastern Time / 1:30 p.m. Pacific Time. To access the conference call, dial toll-free (888) 390-3967, or international at (862) 298-0702. A webcast will also be available at the following link: https://www.webcaster4.com/Webcast/Page/1375/47497
Questions to management may be submitted before the call by emailing them to: ir@genasys.com. A replay of the webcast will be available approximately four hours after the presentation on the Events & Presentations page of the Company’s website.
About Genasys Inc.
Genasys® is a global provider of critical communications systems and innovative solutions that help keep people safe. Genasys provides a multichannel approach to deliver geo-targeted alerts, notifications, instructions, and information before, during, and after public safety and enterprise threats. The Company’s unified software-as-a-service and hardware platform includes Genasys Emergency Management (GEM), Zonehaven™ emergency evacuation resources, National Emergency Warning System (NEWS), Integrated Mass Notification System (IMNS), LRAD® long-range communication systems, and more.
The Genasys critical communications platform is helping to protect millions of people in more than 100 countries. For more information, visit genasys.com.
Forward-Looking Statements
Except for historical information contained herein, the matters discussed are forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, the “safe harbor” provisions of the Private Securities Litigation Reform Act of 1995, and other federal securities laws. You should not place undue reliance on these statements. We base these statements on particular assumptions that we have made in light of our industry experience, the stage of product and market development as well as our perception of historical trends, current market conditions, current economic data, expected future developments and other factors that we believe are appropriate under the circumstances. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those suggested in any forward-looking statement. The risks and uncertainties in these forward-looking statements include without limitation the business impact of epidemics or pandemics, geopolitical conflict, and other causes that may affect our supply chain, and other risks and uncertainties, many of which involve factors or circumstances that are beyond the Company's control. Risks and uncertainties are identified and discussed in our filings with the Securities and Exchange Commission. These forward-looking statements are based on information and management's expectations as of the date hereof. Future results may differ materially from our current expectations. For more information regarding other potential risks and uncertainties, see the "Risk Factors" section of the Company's Form 10-K for the fiscal year ended September 30, 2022. Genasys Inc. disclaims any intent or obligation to publicly update or revise forward-looking statements, except as otherwise specifically stated.
Investor Relations Contacts
Kimberly Rogers
Hayden IR
ir@genasys.com
Genasys Inc.
Condensed Consolidated Balance Sheets
(Unaudited - in thousands)
December 31, | ||||||
2022 | September 30, | |||||
(unaudited) | 2022 | |||||
ASSETS | ||||||
Current assets: | ||||||
Cash and cash equivalents | $ | 7,563 | $ | 12,736 | ||
Short-term marketable securities | 6,551 | 6,397 | ||||
Restricted cash | 738 | 100 | ||||
Accounts receivable, net | 3,297 | 6,744 | ||||
Inventories, net | 8,003 | 6,008 | ||||
Prepaid expenses and other | 2,936 | 3,577 | ||||
Total current assets | 29,088 | 35,562 | ||||
Long-term marketable securities | 1,034 | 781 | ||||
Long-term restricted cash | 96 | 823 | ||||
Deferred tax assets, net | 7,373 | 7,373 | ||||
Property and equipment, net | 1,755 | 1,757 | ||||
Goodwill | 10,308 | 10,118 | ||||
Intangible assets, net | 10,004 | 10,505 | ||||
Operating lease right of use asset | 4,384 | 4,541 | ||||
Prepaid expenses and other - noncurrent | 422 | 394 | ||||
Total assets | $ | 64,464 | $ | 71,854 | ||
LIABILITIES AND STOCKHOLDERS' EQUITY | ||||||
Current liabilities: | ||||||
Accounts payable | $ | 2,609 | $ | 2,334 | ||
Accrued liabilities | 8,075 | 12,083 | ||||
Operating lease liabilities, current portion | 954 | 948 | ||||
Total current liabilities | 11,638 | 15,365 | ||||
Other liabilities, noncurrent | 243 | 907 | ||||
Operating lease liabilities, noncurrent | 4,979 | 5,189 | ||||
Total liabilities | 16,860 | 21,461 | ||||
Total stockholders' equity | 47,604 | 50,393 | ||||
Total liabilities and stockholders' equity | $ | 64,464 | $ | 71,854 |
Genasys Inc.
Condensed Consolidated Statements of Operations
(Unaudited - in thousands, except per share amounts)
Three months ended | |||||||
December 31, | |||||||
2022 | 2021 | ||||||
(unaudited) | (unaudited) | ||||||
Revenues | $ | 10,487 | $ | 10,677 | |||
Cost of revenues | 5,944 | 5,535 | |||||
Gross profit | 4,543 | 5,142 | |||||
Operating expenses: | |||||||
Selling, general and administrative | 6,095 | 5,037 | |||||
Research and development | 1,935 | 1,714 | |||||
Total operating expenses | 8,030 | 6,751 | |||||
Income from operations | (3,487 | ) | (1,609 | ) | |||
Other income and expense, net | (20 | ) | 13 | ||||
Loss before income taxes | (3,507 | ) | (1,596 | ) | |||
Income tax benefit | - | (291 | ) | ||||
Net loss | $ | (3,507 | ) | $ | (1,305 | ) | |
Net loss per common share: | |||||||
Basic and diluted | $ | (0.10 | ) | $ | (0.04 | ) | |
Weighted average common shares outstanding: | |||||||
Basic and diluted | 36,696 | 36,456 | |||||
Reconciliation of GAAP measures to non-GAAP measures | |||||||
Net loss | $ | (3,507 | ) | $ | (1,305 | ) | |
Other income and expense, net | 20 | (13 | ) | ||||
Income tax benefit | - | (291 | ) | ||||
Depreciation and amortization | 643 | 639 | |||||
Stock based compensation | 420 | 558 | |||||
Adjusted EBITDA | $ | (2,424 | ) | $ | (412 | ) |
FAQ
What are Genasys' fiscal Q1 2023 revenue figures?
What drove the strong SaaS bookings in Q1 2023 for GNSS?
How did Genasys' international sales perform in Q1 2023?
What was the net loss reported by Genasys for Q1 2023?